Related Experiment Video
Updated: Jul 1, 2026

A Standardized Acupotomy Protocol For The Treatment of Tenosynovitis of Hand Flexor Tendons In Human Patients
Published on: May 26, 2026
Botulinum toxin use as an adjunctive modality in a patient with multiple flexor tendon ruptures
1Department of Orthopaedic Surgery, Thomas Jefferson University, The Philadelphia Hand Center, 834 Chestnut Street, Suite G114, Philadelphia, PA, 19107, USA. wj.kubat@verizon.net.
Botulinum toxin A effectively treated recurrent flexor tendon ruptures in a patient with hand spasms. This intervention prevented further surgical needs by reducing muscle activity, promoting tendon healing.
Area of Science:
- Neurology
- Orthopedic Surgery
- Dermatology
Background:
- Botulinum toxin A is utilized for various conditions, including hyperhidrosis and esophageal dysfunction.
- Its primary mechanism involves inhibiting acetylcholine release at the neuromuscular junction, causing localized muscle relaxation.
- While known for cosmetic applications, its therapeutic potential in muscle-related injuries is significant.
Purpose of the Study:
- To report a case where Botulinum toxin A was used to manage recurrent flexor tendon repair ruptures in a patient with a history of muscle spasms.
- To illustrate the utility of Botulinum toxin A in promoting tendon healing by reducing detrimental muscle activity.
Main Methods:
- A patient with a history of intermittent diffuse muscle spasms experienced repeated flexor tendon repair ruptures in the index finger.
- Botulinum toxin A was administered to the affected muscle to reduce its activity and prevent further tendon damage.
Main Results:
- Following Botulinum toxin A administration, the patient experienced no further flexor tendon repair ruptures.
- The patient achieved active flexion of all digits without additional surgical interventions.
- The treated muscle's reduced activity facilitated the healing of the repaired flexor tendon.
Conclusions:
- Botulinum toxin A can be a valuable therapeutic option in clinical scenarios requiring decreased muscle activity to aid tendon healing.
- This case highlights the successful application of Botulinum toxin A in managing complex hand injuries complicated by muscle spasms.
- The minimal side effect profile of Botulinum toxin A supports its consideration in cases of detrimental muscle spasm affecting tissue repair.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Botulism
Tetanus
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
